• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,909.39 583.15
(1.11%)
Dow Jones
7,503.05 -1.18
(-0.02%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,664.80 186.46
(1.78%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
540596
INE406M01024
230.588979
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ERIS
79
20055.78
EPS(TTM)
Face Value()
Div & Yield %
18.32
1
0.5
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales267.52306.78637.58
Other Operating Income9.798.5112.92
Other Income 26.9725.0723.59
Total Income304.28340.36674.09
Total Expenditure 255.53252.61353.62
PBIDT48.7587.75320.47
Interest 42.7045.2046.50
PBDT6.0542.55273.97
Depreciation38.8238.6639.30
Tax-7.630.5140.91
Fringe Benefit Tax0.000.000.00
Deferred Tax-16.540.2944.19
Reported Profit After Tax-8.603.09149.57
Extra-ordinary Items 0.00-13.870.00
Adjusted Profit After Extra-ordinary item-8.6016.96149.57
EPS (Unit Curr.)-0.630.2310.98
EPS (Adj) (Unit Curr.)-0.630.2310.98
Calculated EPS (Unit Curr.)-0.620.2310.98
Calculated EPS (Adj) (Unit Curr.)-0.620.2310.98
Calculated EPS (Ann.) (Unit Curr.)-2.480.9143.93
Calculated EPS (Adj) (Ann.) (Unit Curr.)-2.480.9143.93
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.8513.6213.62
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)18.2228.6050.26
PBDTM(%)2.2613.8742.97
PATM(%)-3.211.0123.46